ingrid_STO said:Resolution therefore closed the doors unevenly, and the asymmetry follows from the bulks lists.
Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.
Adding the clinical framing, because it changes how the question reads.
Price comparison for compounded supply across sources I've used:
| Source | Monthly Cost | Type | Purity Verified |
|---|---|---|---|
| Brand (Ozempic) | $957 | FDA-approved | N/A (pharma) |
| 503B Compounding | $137 | cGMP compounded | Yes (in-house) |
| 503A Compounding | $107 | Patient-specific | Varies |
| Research peptide | $47 | Not for human use | Often Janoshik |
I use the 503B option — best balance of quality, cost, and legality. The brand price is insane but insurance can help if you qualify.
SarahChen_PharmD said:Compounded has been just as effective for me.
I have been on both brand and compounded, and in the context of compounded supply, my experience has been equivalent with both. The key is finding a reliable 503B pharmacy with independent testing.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference Standardsrick_sfbay said:The shortage clause is the answer to the second question and it is a subtraction rather than an addition.
Beyond-use dating (BUD) for compounded supply compounded products:
Lyophilized (unreconstituted): typically 6 months from compounding date
Reconstituted with BAC water: typically 28-30 days refrigerated
Reconstituted with sterile water: typically 24 hours (no preservative!)
Always use BAC water for multi-dose vials. Sterile water has no preservative and supports bacterial growth after first puncture. This is a common and potentially dangerous mistake.
Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.